Perennial Advisors, LLC Amgen Inc Transaction History

Perennial Advisors, LLC

$444 Million
Q2 2024

A detailed history of Perennial Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Perennial Advisors, LLC holds 18,323 shares of AMGN stock, worth $5.4 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares

18,323

Previous 18,152 0.94%

Holding current value

$5.4 Million

Previous $5.16 Million 10.95%

% of portfolio

1.29%

Previous 1.21%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$262.75 - $319.31 $44,930 - $54,602	171 Added 0.94%	18,323 $5.73 Million
Q1 2024 Apr 10, 2024	SELL	$268.87 - $324.56 $52,698 - $63,613	-196 Reduced 1.07%	18,152 $5.16 Million
Q4 2023 Jan 25, 2024	BUY	$255.7 - $288.46 $50,117 - $56,538	196 Added 1.08%	18,348 $5.28 Million
Q3 2023 Oct 17, 2023	BUY	$218.65 - $271.46 $27,987 - $34,746	128 Added 0.71%	18,152 $4.88 Million
Q2 2023 Aug 01, 2023	BUY	$214.27 - $253.37 $128,133 - $151,515	598 Added 3.43%	18,024 $4 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $69,994 - $85,312	310 Added 1.81%	17,426 $4.21 Million
Q4 2022 Jan 31, 2023	SELL	$229.03 - $291.01 $141,540 - $179,844	-618 Reduced 3.48%	17,116 $4.5 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $13,916 - $15,695	62 Added 0.35%	17,734 $4 Million
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $45,680 - $50,834	198 Added 1.13%	17,672 $4.3 Million
Q1 2022 Apr 27, 2022	SELL	$219.27 - $242.57 $369,689 - $408,973	-1,686 Reduced 8.8%	17,474 $4.23 Million
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $241,042 - $275,851	-1,212 Reduced 5.95%	19,160 $4.31 Million
Q3 2021 Nov 08, 2021	BUY	$212.27 - $248.7 $203,779 - $238,752	960 Added 4.95%	20,372 $4.33 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $55,592 - $61,675	238 Added 1.24%	19,412 $4.73 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $46,157 - $53,788	208 Added 1.1%	19,174 $4.77 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $105,377 - $125,485	487 Added 2.64%	18,966 $4.36 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $24,872 - $27,660	106 Added 0.58%	18,479 $4.7 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $89,014 - $109,233	450 Added 2.51%	18,373 $4.33 Million
Q1 2020 May 19, 2020	BUY	$182.24 - $241.7 $1.12 Million - $1.48 Million	6,132 Added 52.01%	17,923 $3.63 Million
Q1 2020 May 19, 2020	SELL	$182.24 - $241.7 $857,803 - $1.14 Million	-4,707 Reduced 28.53%	11,791 $1.72 Million
Q4 2019 Jan 23, 2020	BUY	$189.21 - $243.2 $13,055 - $16,780	69 Added 0.42%	16,498 $3.98 Million
Q3 2019 Nov 05, 2019	BUY	$174.11 - $208.62 $89,666 - $107,439	515 Added 3.24%	16,429 $3.18 Million
Q2 2019 Jul 18, 2019	BUY	$166.7 - $195.41 $166,199 - $194,823	997 Added 6.68%	15,914 $2.93 Million
Q1 2019 Apr 30, 2019	BUY	$180.87 - $203.88 $75,965 - $85,629	420 Added 2.9%	14,917 $2.83 Million
Q4 2018 Jan 29, 2019	BUY	$178.4 - $208.25 $85,453 - $99,751	479 Added 3.42%	14,497 $2.82 Million
Q3 2018 Nov 05, 2018	SELL	$185.29 - $208.89 $3,891 - $4,386	-21 Reduced 0.15%	14,018 $2.91 Million
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $90,165 - $101,274	543 Added 4.02%	14,039 $2.59 Million
Q1 2018 Apr 24, 2018	SELL	$169.43 - $198.0 $61,841 - $72,270	-365 Reduced 2.63%	13,496 $2.3 Million
Q4 2017 Jan 29, 2018	BUY	$168.79 - $188.59 $22,449 - $25,082	133 Added 0.97%	13,861 $2.41 Million
Q3 2017 Oct 30, 2017	BUY	$167.29 - $191.0 $2.3 Million - $2.62 Million	13,728	13,728 $2.56 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perennial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perennial Advisors, LLC with notifications on news.

Account

Perennial Advisors, LLC Amgen Inc Transaction History